Abstracts tagged "Disease Activity and juvenile idiopathic arthritis (JIA)"

Abstract Number: 289 • 2013 ACR/ARHP Annual Meeting
Development and Validation Of The Cutoff Values For Disease Activity States Of The Three-Item Version Of The Juvenile Arthritis Disease Activity Score
Alessandro Consolaro¹, Sara Verazza¹, Maria C. Gallo¹, Giulia Bracciolini¹, Giorgia Negro¹, Alessia Frisina¹, Nicolino Ruperto², Alberto Martini^1,3 and Angelo Ravelli^1,3, ¹Pediatria II, Istituto Giannina Gaslini, Genova, Italy, ²PRINTO, Genoa, Italy, ³Department of Pediatrics, University of Genova, Genova, Italy
Background/Purpose: A new approach to the measurement of disease activity in juvenile idiopathic arthritis (JIA) is based on the Juvenile Arthritis Disease Activity Score (JADAS).…
Abstract Number: 296 • 2013 ACR/ARHP Annual Meeting
Declines In Levels Of Disease Activity and Physical Disability In Children With Juvenile Idiopathic Arthritis Seen In Standard Clinical Care Over The Last 25 Years
Alessandro Consolaro¹, Stefano Lanni¹, Francesca Minoia¹, Sergio Davì¹, Sara Dalprà¹, Benedetta Schiappapietra¹, Rossana Pignataro¹, Cristina Ferrari¹, Alberto Martini^1,2 and Angelo Ravelli^3,4, ¹Pediatria II, Istituto Giannina Gaslini, Genova, Italy, ²Department of Pediatrics, University of Genova, Genova, Italy, ³PRINTO, Genoa, Italy, ⁴University of Genova, Genova, Italy
Background/Purpose: Over the last 3 decades there have been important advances in the management of juvenile idiopathic arthritis (JIA), which include the introduction of methotrexate…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].